Lisa M. Holle, PharmD, BCOP, FHOPA
Associate Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT.
Tisagenlecleucel (Kymriah) for Acute Lymphoblastic Leukemia
Tisagenlecleucel (Kymriah) for Acute Lymphoblastic Leukemia
A new era of treatment has arrived—here’s what you need to know.
FDA Approves Rucaparib for Advanced Ovarian Cancer
CE: Pharmacist Perspective on the CDC Guideline for Prescribing Opioids for Chronic Pain

Poll